Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.ebnl.org | |
Market Cap | 13.28 Cr. | |
Enterprise Value(EV) | 7.44 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 0.85 | Trailing Twelve Months Ending 2023-09 |
Price-Earning Ratio (PE) | 31.32 | Trailing Twelve Months Ending 2023-09 |
Industry PE | 38.33 | Trailing Twelve Months Ending 2023-09 |
Book Value / Share | 13.85 | Trailing Twelve Months Ending 2023-09 |
Price to Book Value | 1.92 | Calculated using Price: 26.58 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 0.50 Cr. | 4,996,100 Shares |
FaceValue | 10 | |
About Emmessar Biotech & Nutrition Ltd. | ||
Emmessar Biotech & Nutrition Ltd., was originally started as Emmessar Chemical Industries Ltd on March 17,1992, for manufacturing Super Speciality Fine Chemicals. The Company succeeded in developing many Speciality Fine Chemicals in its own In-house R&D, which was recognised on January 15, 1996 by DSIR, Ministry of Science & Technology, Government of India, New Delhi . |
1 Day |
|
+0.91% |
1 Week |
|
+3.38% |
1 Month |
|
+9.56% |
3 Month |
|
+5.14% |
6 Month |
|
+13.06% |
1 Year |
|
-13.98% |
2 Year |
|
-1.01% |
5 Year |
|
+55.89% |
10 Year |
|
+777.23% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | -7.98 | -40.75 | 78.73 | 36.00 | 16.42 | 19.40 | 29.10 | 8.01 | 7.85 | |
Return on Capital Employed (%) | -10.49 | -59.37 | 79.46 | 31.46 | 9.00 | 18.87 | 45.29 | 15.71 | 14.99 | |
Return on Assets (%) | -5.08 | -20.32 | 44.83 | 26.93 | 12.75 | 14.93 | 22.47 | 6.30 | 6.42 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 1 | 1 | 2 | 3 | 4 | 4 | 6 | 6 | 7 | 7 | |
Non Curr. Liab. | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | ||
Curr. Liab. | 1 | 1 | 0 | 0 | 1 | 1 | 2 | 1 | 1 | 0 | |
Minority Int. | |||||||||||
Equity & Liab. | 2 | 2 | 3 | 4 | 5 | 5 | 7 | 8 | 8 | 8 | |
Non Curr. Assets | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |
Curr. Assets | 1 | 1 | 1 | 1 | 3 | 3 | 6 | 6 | 6 | 6 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 2 | 2 | 3 | 4 | 5 | 5 | 7 | 8 | 8 | 8 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09 Rs. Cr. TTM |
Net Sales | 2 | 2 | 3 | 1 | 1 | 3 | 7 | 0 | 1 | 1 | |
Other Income | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | |
Total Income | 2 | 2 | 4 | 3 | 2 | 5 | 8 | 2 | 3 | 3 | |
Total Expenditure | -2 | -2 | -2 | -2 | -1 | -4 | -6 | -1 | -2 | -2 | |
PBIDT | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | |
Interest | 0 | ||||||||||
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Taxation | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | -1 | ||
Exceptional Items | -1 | 0 | 0 | ||||||||
PAT | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | |
Adjusted EPS | 0 | -1 | 2 | 2 | 1 | 2 | 3 | 1 | 1 | 1 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 2 | 0 | ||
Cash Fr. Inv. | 0 | -1 | -1 | 0 | -1 | 0 | -3 | -1 | |||
Cash Fr. Finan. | |||||||||||
Net Change | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
Sat, 09 Dec 2023
Board Meeting Outcome for Outcome Of Board Meeting The Board of Directors at their meeting today approved and took on record the Un-Audited Financial Results for the second quarter ended September 30 2023 |
Tue, 28 Nov 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication Pursuant to the provisions of Reg 30 & 47 of SEBI(LODR) Regulations 2015 the newspaper clippings regarding the intimation of Board Meeting to be held on Saturday December 09 2023 at 12 Noon published in the Free Press Journal & Nav Shakti dt 28-11-2023 are attached. |
Mon, 27 Nov 2023
Board Meeting Intimation for For Un-Audited Quarterly Result For September 30 2023 EMMESSAR BIOTECH & NUTRITION LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/12/2023 inter alia to consider and approve Pursuant to Reg. 29 & 33 of SEBI (LODR) Regulations 2015 a meeting of Board of Directors will be held on Saturday December 09 2023 at 12 Noon to consider & Approve the Un-Audited Financial Result for the Quarter Ended September 30 2023. |
Mon, 11 Dec 2023 |
|
|
|
|
|